Literature DB >> 22797744

Progress, challenges, and new opportunities for the prevention of mother-to-child transmission of HIV under the US President's Emergency Plan for AIDS Relief.

Benjamin H Chi1, Michelle R Adler, Omotayo Bolu, Dorothy Mbori-Ngacha, Didier K Ekouevi, Anna Gieselman, Tsungai Chipato, Chewe Luo, B Ryan Phelps, Craig McClure, Lynne M Mofenson, Jeffrey S A Stringer.   

Abstract

In June 2011, the Joint United Nations Programme on HIV/AIDS, the US President's Emergency Plan for AIDS Relief (PEPFAR), and other collaborators outlined a transformative plan to virtually eliminate pediatric AIDS worldwide. The ambitious targets of this initiative included a 90% reduction in new pediatric HIV infections and a 50% reduction in HIV-related maternal mortality--all by 2015. PEPFAR has made an unprecedented commitment to the expansion and improvement of prevention of mother-to-child HIV transmission (PMTCT) services globally and is expected to play a critical role in reaching the virtual elimination target. To date, PEPFAR has been instrumental in the success of many national programs, including expanded coverage of PMTCT services, an enhanced continuum of care between PMTCT and HIV care and treatment, provision of more efficacious regimens for antiretroviral prophylaxis, design of innovative but simplified PMTCT approaches, and development of new strategies to evaluate program effectiveness. These accomplishments have been made through collaborative efforts with host governments, United Nations agencies, other donors (eg, the Global Fund for AIDS, Tuberculosis, and Malaria), nongovernmental organizations, and private sector partners. To successfully meet the ambitious global targets to prevent new infant HIV infections, PEPFAR must continue to leverage the existing PMTCT platform, while developing innovative approaches to rapidly expand quality HIV services. PEPFAR must also carefully integrate PMTCT into the broader combination prevention agenda for HIV, so that real progress can be made toward an "AIDS-free generation" worldwide.

Entities:  

Mesh:

Year:  2012        PMID: 22797744     DOI: 10.1097/QAI.0b013e31825f3284

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  39 in total

Review 1.  Implementation Research for the Prevention of Mother-to-Child HIV Transmission in Sub-Saharan Africa: Existing Evidence, Current Gaps, and New Opportunities.

Authors:  Sanjana Bhardwaj; Bryan Carter; Gregory A Aarons; Benjamin H Chi
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

2.  Massive benefits of antiretroviral therapy in Africa.

Authors:  Sten H Vermund
Journal:  J Infect Dis       Date:  2013-12-03       Impact factor: 5.226

3.  Consistency of State Statutes and Regulations With Centers for Disease Control and Prevention's 2006 Perinatal HIV Testing Recommendations.

Authors:  Sheila Salvant Valentine; Amelia Poulin
Journal:  Public Health Rep       Date:  2018-08-10       Impact factor: 2.792

4.  Implementation and Operational Research: Integration of PMTCT and Antenatal Services Improves Combination Antiretroviral Therapy Uptake for HIV-Positive Pregnant Women in Southern Zambia: A Prototype for Option B+?

Authors:  Julie M Herlihy; Leoda Hamomba; Rachael Bonawitz; Caitlin E Goggin; Kennedy Sambambi; Jonas Mwale; Victor Musonda; Kebby Musokatwane; Kathryn L Hopkins; Katherine Semrau; Emily E Hammond; Julie Duncan; Anna B Knapp; Donald M Thea
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-01       Impact factor: 3.731

Review 5.  HIV-1 vaccines: challenges and new perspectives.

Authors:  Jean-Louis Excler; Merlin L Robb; Jerome H Kim
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

6.  Investments in blood safety improve the availability of blood to underserved areas in a sub-Saharan African country.

Authors:  J P Pitman; R Wilkinson; S V Basavaraju; B von Finckenstein; C Smit Sibinga; A A Marfin; M J Postma; M Mataranyika; J Tobias; D W Lowrance
Journal:  ISBT Sci Ser       Date:  2014-12-01

Review 7.  Antiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan Africa.

Authors:  Benjamin H Chi; Jeffrey S A Stringer; Dhayendre Moodley
Journal:  Curr HIV/AIDS Rep       Date:  2013-06       Impact factor: 5.071

8.  HLA-G 14 bp deletion/insertion polymorphism and mother-to-child transmission of HIV.

Authors:  L Segat; L Zupin; H-Y Kim; E Catamo; D M Thea; C Kankasa; G M Aldrovandi; L Kuhn; S Crovella
Journal:  Tissue Antigens       Date:  2014-03

9.  Temporal changes in the outcomes of HIV-exposed infants in Kinshasa, Democratic Republic of Congo during a period of rapidly evolving guidelines for care (2007-2013).

Authors:  Lydia Feinstein; Andrew Edmonds; Jean Lambert Chalachala; Vitus Okitolonda; Jean Lusiama; Annelies Van Rie; Benjamin H Chi; Stephen R Cole; Frieda Behets
Journal:  AIDS       Date:  2014-07       Impact factor: 4.177

10.  Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.

Authors:  Maria Lahuerta; Yingfeng Wu; Susie Hoffman; Batya Elul; Sarah Gorrell Kulkarni; Robert H Remien; Harriet Nuwagaba-Biribonwoha; Wafaa El-Sadr; Denis Nash
Journal:  Clin Infect Dis       Date:  2013-11-05       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.